UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
When the trial ends: The case for post-trial provisions in clinical psychedelic research
We show how conceiving of post-trial provision as an integral site of the research process, and an appropriate destination for research funding, will serve to develop the infrastructure necessary for the post-legalisation psychedelic medicine ecosystem.
Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability
Despite the methodological limitations, we conclude that from a clinical view, maintenance ketamine treatment seems to be of therapeutic potential.
Sustained effects of single doses of classical psychedelics in humans
A unique and compelling feature of psychedelics is that intake of just a single psychedelic dose is associated with long-lasting effects.
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
These findings demonstrate that the substantial antidepressant effects of psilocybin-assisted therapy may be durable at least through 12 months following acute intervention in some patients.
Sustained, multifaceted improvements in mental well-being following psychedelic experiences in a prospective opportunity sample
improvements in mental well-being following psychedelic experiences